{"id":9736,"date":"2022-01-03T20:16:53","date_gmt":"2022-01-03T20:16:53","guid":{"rendered":"https:\/\/haugpartners.com\/?post_type=article&#038;p=9736"},"modified":"2024-09-26T09:05:46","modified_gmt":"2024-09-26T09:05:46","slug":"astrazeneca-ab-v-mylan-pharms-inc-claim-construction-of-a-percentage-term-guided-by-the-written-description-and-prosecution-history","status":"publish","type":"article","link":"https:\/\/haugpartners.com\/article\/astrazeneca-ab-v-mylan-pharms-inc-claim-construction-of-a-percentage-term-guided-by-the-written-description-and-prosecution-history\/","title":{"rendered":"<i>AstraZeneca AB v. Mylan Pharms. Inc.<\/i>: Claim Construction of a Percentage Term Guided by the Written Description and Prosecution History"},"featured_media":0,"template":"","categories":[98],"acf":[],"_links":{"self":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article\/9736"}],"collection":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media?parent=9736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/categories?post=9736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}